In acute myeloid leukemia, ZRF1 is a regulator of RA-induced differentiation [16], and because of the relevance of retinoids in neuroblastoma therapy [22], we investigated whether ZRF1 interferes with the response of neuroblastoma cells to RA. Here, DNAJC2 is linked to neuroblastoma.